Trellis Bioscience, Inc. Appoints John Wulf as EVP, Business Operations and Chief Business Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Trellis Bioscience, a privately held biotechnology company, today announced the appointment of John J. Wulf as Executive Vice President, Business Operations and Chief Business Officer. Mr. Wulf, a senior corporate development executive with over 20 years experience within the biotechnology industry, joins Trellis Bioscience from Y’s Therapeutics, where he was President, Chief Operating Officer and Chief Business Officer.